Nova Cannabis Inc.

NOVC.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NOVC.TO stands at 108.02M. In comparison, NBLY.TO has a market cap of 835.48M. Regarding current trading prices, NOVC.TO is priced at $1.74, while NBLY.TO trades at $18.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NOVC.TO currently has a P/E ratio of 34.80, whereas NBLY.TO's P/E ratio is -25.48. In terms of profitability, NOVC.TO's ROE is +0.06%, compared to NBLY.TO's ROE of -0.05%. Regarding short-term risk, NOVC.TO is less volatile compared to NBLY.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NOVC.TO.

NOVC.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NOVC.TO stands at 108.02M. In comparison, FAF.TO has a market cap of 13.09M. Regarding current trading prices, NOVC.TO is priced at $1.74, while FAF.TO trades at $0.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NOVC.TO currently has a P/E ratio of 34.80, whereas FAF.TO's P/E ratio is -0.14. In terms of profitability, NOVC.TO's ROE is +0.06%, compared to FAF.TO's ROE of -0.97%. Regarding short-term risk, NOVC.TO is less volatile compared to FAF.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NOVC.TO.

NOVC.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NOVC.TO stands at 108.02M. In comparison, GABY.CN has a market cap of 3.67M. Regarding current trading prices, NOVC.TO is priced at $1.74, while GABY.CN trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NOVC.TO currently has a P/E ratio of 34.80, whereas GABY.CN's P/E ratio is -0.08. In terms of profitability, NOVC.TO's ROE is +0.06%, compared to GABY.CN's ROE of +2.91%. Regarding short-term risk, NOVC.TO and GABY.CN have similar daily volatility (0.00).

NOVC.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NOVC.TO stands at 108.02M. In comparison, IWIN.CN has a market cap of 1.01M. Regarding current trading prices, NOVC.TO is priced at $1.74, while IWIN.CN trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NOVC.TO currently has a P/E ratio of 34.80, whereas IWIN.CN's P/E ratio is -0.03. In terms of profitability, NOVC.TO's ROE is +0.06%, compared to IWIN.CN's ROE of -0.21%. Regarding short-term risk, NOVC.TO and IWIN.CN have similar daily volatility (0.00).

NOVC.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NOVC.TO stands at 108.02M. In comparison, TREE.NE has a market cap of 1.01M. Regarding current trading prices, NOVC.TO is priced at $1.74, while TREE.NE trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NOVC.TO currently has a P/E ratio of 34.80, whereas TREE.NE's P/E ratio is -0.17. In terms of profitability, NOVC.TO's ROE is +0.06%, compared to TREE.NE's ROE of +1.63%. Regarding short-term risk, NOVC.TO and TREE.NE have similar daily volatility (0.00).